155 related articles for article (PubMed ID: 35323369)
21. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
22. Incidence of brain metastasis from esophageal cancer.
Welch G; Ross HJ; Patel NP; Jaroszewski DE; Fleischer DE; Rule WG; Paripati HR; Ramirez FC; Ashman JB
Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859365
[TBL] [Abstract][Full Text] [Related]
23. Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.
Davis FG; Dolecek TA; McCarthy BJ; Villano JL
Neuro Oncol; 2012 Sep; 14(9):1171-7. PubMed ID: 22898372
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
25. Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer.
Hayashi N; Mitsuya K; Nakasu Y; Naito T; Ohka F; Takahashi T
J Neurooncol; 2017 Nov; 135(2):299-306. PubMed ID: 28752500
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis.
Liu H; Xu YB; Guo CC; Li MX; Ji JL; Dong RR; Zhang LL; He XX
Cancer Med; 2019 Dec; 8(18):7577-7585. PubMed ID: 31657530
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer and brain metastases: An aggressive disease with a different response to treatment.
Chahine G; Ibrahim T; Felefly T; El-Ahmadie A; Freiha P; El-Khoury L; Khalife-Saleh N; Saleh K
Tumori; 2019 Oct; 105(5):427-433. PubMed ID: 29714653
[TBL] [Abstract][Full Text] [Related]
28. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
[TBL] [Abstract][Full Text] [Related]
29. Metastasis directed treatment of brain metastases from colorectal cancer - a Danish population-based cohort study.
Boysen AK; Ording AG; Astradsson A; Høyer M; Spindler KL
Acta Oncol; 2020 Sep; 59(9):1118-1122. PubMed ID: 32441550
[No Abstract] [Full Text] [Related]
30. Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer.
Ding X; Dai H; Hui Z; Ji W; Liang J; Lv J; Zhou Z; Yin W; He J; Wang L
Radiat Oncol; 2012 Jul; 7():119. PubMed ID: 22846375
[TBL] [Abstract][Full Text] [Related]
31. Incidence and Prognosis of Brain Metastases in Head and Neck Cancer Patients at Diagnosis.
Messing I; Goyal S; Sherman JH; Thakkar P; Siegel R; Joshi A; Goodman J; Ojong-Ntui M; Rao YJ
Laryngoscope; 2021 Sep; 131(9):E2543-E2552. PubMed ID: 33599979
[TBL] [Abstract][Full Text] [Related]
32. Rare cancers in Canada, 2006-2016: A population-based surveillance report and comparison of different methods for classifying rare cancers.
Walker EV; Maplethorpe E; Davis FG
Cancer Epidemiol; 2020 Aug; 67():101721. PubMed ID: 32416499
[TBL] [Abstract][Full Text] [Related]
33. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract][Full Text] [Related]
34. Systematic review: brain metastases from colorectal cancer--Incidence and patient characteristics.
Christensen TD; Spindler KL; Palshof JA; Nielsen DL
BMC Cancer; 2016 Apr; 16():260. PubMed ID: 27037031
[TBL] [Abstract][Full Text] [Related]
35. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China.
Li Y; Li Q; Mo H; Guan X; Lin S; Wang Z; Chen Y; Zhang Y; Zhang D; Chen S; Cai R; Wang J; Luo Y; Fan Y; Yuan P; Zhang P; Li Q; Ma F; Xu B
Breast; 2021 Feb; 55():30-36. PubMed ID: 33310633
[TBL] [Abstract][Full Text] [Related]
36. Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer.
Burudpakdee C; Wong W; Seetasith A; Corvino FA; Yeh W; Gubens M
Lung Cancer; 2018 May; 119():103-111. PubMed ID: 29656744
[TBL] [Abstract][Full Text] [Related]
37. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
38. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
[TBL] [Abstract][Full Text] [Related]
39. Incidence and predictors of brain metastasis in colorectal cancer patients.
Thompson E; Banerjee S; Thompson S; Silva R; Muse A; Arif-Tiwari H; Scott AJ; Nfonsam V
Int J Colorectal Dis; 2022 Jan; 37(1):153-159. PubMed ID: 34596736
[TBL] [Abstract][Full Text] [Related]
40. 1992 Canadian Cancer Statistics.
Illing EM; Gaudette LA; McLaughlin J; McBride M
Health Rep; 1992; 4(2):161-74. PubMed ID: 1421019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
